68Ga-PSMA-11 PET-CT imaging was firstly introduced in 2013 by Afshar-Oromieh et al. in 37 patients with relapsing prostate cancer (Figure 19) [107,145]. This evidence concerns the gene FOLH1 and prostate cancer.